Source: ALL
Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
MPL proto-oncogene, thrombopoietin receptor | 0.510 | 0.692 | 4.1E-09 |
|
disease | 0.500 | None | 0.979 | 95 | 5 | 1995 | 2020 | ||||||||
|
KIT proto-oncogene, receptor tyrosine kinase | 0.366 | 0.808 | 0.98 |
|
disease | 0.480 | None | 1.000 | 10 | 1 | 1994 | 2015 | ||||||||
|
Janus kinase 3 | 0.505 | 0.731 | 5.9E-06 |
|
disease | 0.400 | None | 1.000 | 4 | 1 | 2010 | 2014 | ||||||||
|
DNA ligase 4 | 0.478 | 0.846 | 4.2E-06 |
|
disease | 0.310 | strong | 1.000 | 2 | 0 | 2001 | 2015 | ||||||||
|
centromere protein E | 0.636 | 0.692 | 0.24 |
|
disease | 0.310 | None | 1.000 | 1 | 0 | 2014 | 2014 | ||||||||
|
Janus kinase 2 | 0.385 | 0.885 | 0.65 |
|
disease | 0.300 | None | 0.979 | 516 | 12 | 2005 | 2020 | ||||||||
|
platelet derived growth factor receptor beta | 0.416 | 0.846 | 0.90 |
|
disease | 0.300 | None | 1.000 | 24 | 0 | 2003 | 2019 | ||||||||
|
ASXL transcriptional regulator 1 | 0.482 | 0.808 | 1.3E-14 |
|
disease | 0.300 | None | 1.000 | 13 | 0 | 2010 | 2019 | ||||||||
|
centromere protein F | 0.601 | 0.654 | 1.9E-36 |
|
disease | 0.300 | strong | 1.000 | 1 | 0 | 2015 | 2015 | ||||||||
|
insulin like growth factor 1 | 0.318 | 0.885 | 0.27 |
|
disease | 0.300 | strong | 1.000 | 1 | 0 | 1996 | 1996 | ||||||||
|
cell division cycle 6 | 0.552 | 0.731 | 1.1E-09 |
|
disease | 0.300 | None | 1.000 | 1 | 0 | 2012 | 2012 | ||||||||
|
chromatin licensing and DNA replication factor 1 | 0.597 | 0.731 | 2.6E-10 |
|
disease | 0.300 | strong | 1.000 | 1 | 0 | 2011 | 2011 | ||||||||
|
origin recognition complex subunit 6 | 0.628 | 0.577 | 3.4E-07 |
|
disease | 0.300 | strong | 1.000 | 1 | 0 | 2011 | 2011 | ||||||||
|
geminin DNA replication inhibitor | 0.554 | 0.808 | 0.11 |
|
disease | 0.300 | strong | 1.000 | 1 | 0 | 2015 | 2015 | ||||||||
|
origin recognition complex subunit 4 | 0.612 | 0.654 | 7.6E-13 |
|
disease | 0.300 | strong | 1.000 | 1 | 0 | 2011 | 2011 | ||||||||
|
origin recognition complex subunit 1 | 0.595 | 0.654 | 1.7E-14 |
|
disease | 0.300 | strong | 1.000 | 1 | 0 | 2011 | 2011 | ||||||||
|
WD repeat domain 4 | 0.653 | 0.538 | 1.4E-08 |
|
disease | 0.300 | moderate | 1.000 | 1 | 0 | 2018 | 2018 | ||||||||
|
TRAF interacting protein | 0.644 | 0.654 | 1.6E-05 |
|
disease | 0.300 | strong | 1.000 | 1 | 0 | 2016 | 2016 | ||||||||
|
X-ray repair cross complementing 4 | 0.528 | 0.769 | 8.3E-07 |
|
disease | 0.300 | strong | 1.000 | 1 | 0 | 2014 | 2014 | ||||||||
|
ATR serine/threonine kinase | 0.456 | 0.923 | 3.5E-09 |
|
disease | 0.300 | strong | 0 | 0 | |||||||||||
|
ATR interacting protein | 0.666 | 0.692 | 2.0E-05 |
|
disease | 0.300 | limited | 0 | 0 | |||||||||||
|
pericentrin | 0.564 | 0.808 | 4.0E-58 |
|
disease | 0.300 | strong | 0 | 0 | |||||||||||
|
ABL proto-oncogene 1, non-receptor tyrosine kinase | 0.432 | 0.923 | 1.00 |
|
disease | 0.100 | None | 0.975 | 159 | 0 | 1993 | 2020 | ||||||||
|
calreticulin | 0.413 | 0.923 | 0.89 |
|
disease | 0.100 | None | 0.980 | 102 | 0 | 2014 | 2020 | ||||||||
|
BCR activator of RhoGEF and GTPase | 0.431 | 0.885 | 0.99 |
|
disease | 0.100 | None | 0.942 | 69 | 0 | 1992 | 2019 |